Prevention of iron deficiency and iron-deficiency anemia: Current positions and strategy
Abstract. Iron deficiency (ID) is a significant modern healthcare problem that, despite ongoing programs by the World Health Organization, remains unresolved. Iron deficiency (ID), and iron deficiency anemia as its most severe manifestation, reduces quality of life, worsens comorbid conditions, and increases the risk of hospitalization and death. The most successful strategy for combating ID is timely preventive measures, including informational and educational activities, balanced nutrition, implementation of national iron fortification programs, screening for ID, regular follow-up, and iron supplementation in individuals from the risk groups. Among modern supplementation methods (prevention and correction of ID), iron bisglycinate (VitaFerr) deserves special attention: this form of iron, characterized by good absorption rates, has proven its efficacy and safety in a number of studies and in real-world clinical practice, as is illustrated by the clinical observations presented in the current article.N.О. Khovasova, A.V. Naumov
Keywords
iron deficiency
iron deficiency anemia
nutrition
iron deficiency prevention
iron supplementation
iron bisglycinate
References
1. Piessens V, Rodriguez Benito L, Oztora S, Martins C, Brodersen JB. Seven ways to optimise prevention in general practice and family medicine – a EUROPREV position paper to spark debate on prevention. Eur J Gen Pract. 2025;31(1):2531880.
PMID: 40698523. PMCID: PMC12288180. https://doi.org/10.1080/13814788.2025.2531880
2. Martins C, Godycki-Cwirko M, Heleno B, Brodersen J. Quaternary prevention: Reviewing the concept. Eur J Gen Pract.
2018;24(1):106–11.
PMID: 29384397. PMCID: PMC5795741. https://doi.org/10.1080/13814788.2017.1422177
3. Passarelli S, Free CM, Shepon A, Beal T, Batis C, Golden CD. Global estimation of dietary micronutrient inadequacies: A modelling analysis. Lancet Glob Health. 2024;12(10):e1590–e1599.
PMID: 39218000. PMCID: PMC11426101. https://doi.org/10.1016/S2214-109X(24)00276-6
4. Qiu Y, Long Z, Long Z. Epidemiology of dietary iron deficiency in China from 1990 to 2021: Findings from the global burden of disease study 2021. BMC Public Health. 2025;25(1):596.
PMID: 39948490. PMCID: PMC11823194. https://doi.org/10.1186/s12889-025-21665-z
5. Teh MR, Armitage AE, Drakesmith H. Why cells need iron: A compendium of iron utilisation. Trends Endocrinol Metab. 2024;35(12):1026–49.
PMID: 38760200. PMCID: PMC1161662. https://doi.org/10.1016/j.tem.2024.04.015
6. Federico G, Carrillo F, Dapporto F, Chiariello M, Santoro M, Bellelli R, Carlomagno F. NCOA4 links iron bioavailability to DNA metabolism. Cell Rep. 2022;40(7):111207.
PMID: 35977492. https://doi.org/10.1016/j.celrep.2022.111207
7. Farida B, Ibrahim KG, Abubakar B, Malami I, Bello MB, Abubakar MB et al. Iron deficiency and its epigenetic effects on iron homeostasis. J Trace Elem Med Biol. 2023;78:127203.
PMID: 37201368. https://doi.org/10.1016/j.jtemb.2023.127203
8. Aly SS, Fayed HM, Ismail AM, Abdel Hakeem GL. Assessment of peripheral blood lymphocyte subsets in children with iron deficiency anemia. BMC Pediatr. 2018;18(1):49.
PMID: 29433459. PMCID: PMC5809939. https://doi.org/10.1186/s12887-018-0990-5
9. Jonker FA, Boele van Hensbroek M. Anaemia, iron deficiency and susceptibility to infections. J Infect. 2014;69 Suppl 1:S23–27.
PMID: 25264159. https://doi.org/10.1016/j.jinf.2014.08.007
10. Fairweather-Tait SJ, Wawer AA, Gillings R, Jennings A, Myint PK. Iron status in the elderly. Mech Ageing Dev. 2014;136–137:22–28.
PMID: 24275120. PMCID: PMC4157323. https://doi.org/10.1016/j.mad.2013.11.005
11. World Health Organization. Nutritional anaemias: Tools for effective prevention and control. 13 November 2017. URL: https://www.who.int/publications/i/item/9789241513067 (date of access – 12.10.2025).
12. Hurrell RF, Reddy MB, Juillerat M, Cook JD. Meat protein fractions enhance nonheme iron absorption in humans. J Nutr. 2006;136(11):2808–12.
PMID: 17056805. https://doi.org/10.1093/jn/136.11.2808
13. Brittenham GM, Moir-Meyer G, Abuga KM, Datta-Mitra A, Cerami C, Green R et al. Biology of anemia: A public health perspective. J Nutr. 2023;153 Suppl 1:S7–S28.
PMID: 37778889. PMCID: PMC7618251. https://doi.org/10.1016/j.tjnut.2023.07.018
14. Wagiu Basrowi R, Sundjaya T, Pratiwi D, Amalia N, Tandi YYP, Syafa’atulloh MY et al. Harnessing the power of proteins in modulation of miRNAs for targeting Iron deficiency Anemia: Opinion for future implications and strategies. Front Nutr. 2025;12:1535498.
PMID: 39931366. PMCID: PMC11807793. https://doi.org/10.3389/fnut.2025.1535498
15. Lo JO, Benson AE, Martens KL, Hedges MA, McMurry HS, DeLoughery T et al. The role of oral iron in the treatment of adults with iron deficiency. Eur J Haematol. 2023;110(2):123–30.
PMID: 36336470. PMCID: PMC9949769. https://doi.org/10.1111/ejh.13892
16. Milman N, Jonsson L, Dyre P, Pedersen PL, Larsen LG. Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial. J Perinat Med. 2014;42(2):197–206.
PMID: 24152889. https://doi.org/10.1515/jpm-2013-0153
17. Yu X, Chen L, Ding H, Zhao Y, Feng J. Iron transport from ferrous bisglycinate and ferrous sulfate in DMT1-knockout human intestinal Caco-2 Cells. Nutrients. 2019;11(3):485.
PMID: 30813537. PMCID: PMC6470600. https://doi.org/10.3390/nu11030485
18. Bumrungpert A, Pavadhgul P, Piromsawasdi T, Mozafari MR. Efficacy and safety of ferrous bisglycinate and folinic acid in the control of iron deficiency in pregnant women: A randomized, controlled trial. Nutrients. 2022;14(3):452.
PMID: 35276810. PMCID: PMC8839493. doi: 10.3390/nu14030452
19. ClinicalTrials.gov Identifier: NCT01160198. A study to demonstrate the efficacy and tolerability of ferrous bisglycinate chelate in iron deficiency anaemia and to compare these with those of ferrous ascorbate. Bethesda, MD: National Library of Medicine (US); 2018. URL: https://clinicaltrials.gov/ct2/show/NCT01160198 (date of access – 12.10.2025).
About the Authors
Natalia O. Khovassova, MD, Dr. Sci. (Medicine), professor of the Department of aging-related diseases of the Institute of Continuous Education and Professional Development, senior researcher at the Department of musculoskeletal diseases, Russian Gerontological Research and Clinical Center of N.I. Pirogov Russian National Research Medical University (Pirogov University), Moscow, Russian Federation.E-mail: natashahov@mail.ru
ORCID: https://orcid.org/0000-0002-3066-4866. eLibrary SPIN: 7387-7710. Scopus ID: 56380425300
Anton V. Naumov, MD, Dr. Sci. (Medicine), head of the Department of musculoskeletal diseases, Russian Gerontological Research and Clinical Center; professor of the Department of aging-related diseases of the Institute of Continuous Education and Professional Development, N. I. Pirogov Russian National Research Medical University, Moscow, Russian Federation.
E-mail: nanton78@gmail.com
ORCID: https://orcid.org/0000-0002-6253-621X. eLibrary SPIN: 4763-9738. Scopus ID: 23983006900
Similar Articles
